Explore a significant study on treatment-resistant major depressive disorder in this episode. We examine the potential benefits of esketamine nasal spray versus extended-release quetiapine, both used in combination with an SSRI or SNRI. The findings could change the future approach to treating this prevalent condition.
🎙️ State of Health Podcast: open.spotify.com/show/7JWc9FS...
Prior Episodes:
Depression and Psilocybin: • Depression and Psilocy...
Postpartum Hemorrhage: • Postpartum hemorrhage:...
Video vs Direct Laryngoscopy: • Video vs Direct Laryng...
Building a Better Insulin: • Better Insulin and the...
Join this channel to get access to perks:
/ @medzcool
DISCLAIMER
⚠️ For Healthcare Practitioners: This content is provided only for medical education. Although the authors have made every effort to provide the most up-to-date, evidence-based medical information, this content should not necessarily be considered the standard of care. It may not reflect individual practices in other geographic locations. It should be considered in the context of other medical educational resources.
⚠️ For the Public: This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. You should contact your own physician or other qualified healthcare providers with any questions you may have regarding your medical condition. Do not disregard professional medical advice or delay seeking it based on information from this content. Relying on information provided in this content is done at your own risk. In a medical emergency, contact your physician or call 9-1-1 immediately.